• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.25"; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.25"; INTRAVASCULAR CATHETER Back to Search Results
Model Number 383537
Device Problem Missing Information (4053)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/21/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported while using nexiva dual port with q-syte, 20g x 1.25" the label was missing.The following information was provided by the initial reporter: one out of 4 boxes in the case, was send without labels.
 
Event Description
It was reported while using nexiva dual port with q-syte, 20g x 1.25" the label was missing.The following information was provided by the initial reporter: one out of 4 boxes in the case, was send without labels.
 
Manufacturer Narrative
H.6.Investigation: our quality engineer inspected the photograph submitted for evaluation.Bd received one photograph which displayed the dispenser box label missing.The reported issue was confirmed.This was physical/mechanical evidence to confirm and support a manufacturing process related issue for the reported defect relating to the packaging process.A missing dispenser box label may occur during the packaging process due to incorrect setup/jam or during manual labeling due to operator error.Periodic inspections and setup are performed per the quality plan as well as operator training for the packaging process.Preventative maintenance (pm) is also performed to ensure proper functioning of the equipment during the automated labeling process.The pm records were reviewed and verified as up to date during the manufacturing of this lot.A device history record review showed no non-conformances associated with this issue during the production of this batch.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA DUAL PORT WITH Q-SYTE, 20G X 1.25"
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14073371
MDR Text Key289012469
Report Number1710034-2022-00178
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835370
UDI-Public30382903835370
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/11/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number383537
Device Catalogue Number383537
Device Lot Number1298357
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-